These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 15809732

  • 1. Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas.
    Geli J, Nord B, Frisk T, Edström Elder E, Ekström TJ, Carling T, Bäckdahl M, Larsson C.
    Int J Oncol; 2005 May; 26(5):1385-91. PubMed ID: 15809732
    [Abstract] [Full Text] [Related]

  • 2. Loss of heterozygosity on the short arm of chromosome 1 in pheochromocytoma and abdominal paraganglioma.
    Edström Elder E, Nord B, Carling T, Juhlin C, Bäckdahl M, Höög A, Larsson C.
    World J Surg; 2002 Aug; 26(8):965-71. PubMed ID: 12045857
    [Abstract] [Full Text] [Related]

  • 3. Biallelic inactivation of the RIZ1 gene in human gastric cancer.
    Tokumaru Y, Nomoto S, Jerónimo C, Henrique R, Harden S, Trink B, Sidransky D.
    Oncogene; 2003 Oct 09; 22(44):6954-8. PubMed ID: 14534544
    [Abstract] [Full Text] [Related]

  • 4. Intragenic allelic loss and promoter hypermethylation of the RIZ1 tumor suppressor gene in parathyroid tumors and pheochromocytomas.
    Carling T, Du Y, Fang W, Correa P, Huang S.
    Surgery; 2003 Dec 09; 134(6):932-9; discussion 939-40. PubMed ID: 14668725
    [Abstract] [Full Text] [Related]

  • 5. Recurrent genomic alterations in benign and malignant pheochromocytomas and paragangliomas revealed by whole-genome array comparative genomic hybridization analysis.
    Sandgren J, Diaz de Ståhl T, Andersson R, Menzel U, Piotrowski A, Nord H, Bäckdahl M, Kiss NB, Brauckhoff M, Komorowski J, Dralle H, Hessman O, Larsson C, Akerström G, Bruder C, Dumanski JP, Westin G.
    Endocr Relat Cancer; 2010 Sep 09; 17(3):561-79. PubMed ID: 20410162
    [Abstract] [Full Text] [Related]

  • 6. Comparative genomic hybridization reveals frequent losses of chromosomes 1p and 3q in pheochromocytomas and abdominal paragangliomas, suggesting a common genetic etiology.
    Edström E, Mahlamäki E, Nord B, Kjellman M, Karhu R, Höög A, Goncharov N, Teh BT, Bäckdahl M, Larsson C.
    Am J Pathol; 2000 Feb 09; 156(2):651-9. PubMed ID: 10666394
    [Abstract] [Full Text] [Related]

  • 7. Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior.
    Geli J, Kiss N, Karimi M, Lee JJ, Bäckdahl M, Ekström TJ, Larsson C.
    Clin Cancer Res; 2008 May 01; 14(9):2551-9. PubMed ID: 18451216
    [Abstract] [Full Text] [Related]

  • 8. Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas.
    Kytölä S, Nord B, Elder EE, Carling T, Kjellman M, Cedermark B, Juhlin C, Höög A, Isola J, Larsson C.
    Genes Chromosomes Cancer; 2002 Jul 01; 34(3):325-32. PubMed ID: 12007193
    [Abstract] [Full Text] [Related]

  • 9. Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.
    Kiss NB, Geli J, Lundberg F, Avci C, Velazquez-Fernandez D, Hashemi J, Weber G, Höög A, Ekström TJ, Bäckdahl M, Larsson C.
    Endocr Relat Cancer; 2008 Jun 01; 15(2):609-21. PubMed ID: 18509008
    [Abstract] [Full Text] [Related]

  • 10. RIZ1 is epigenetically inactivated by promoter hypermethylation in thyroid carcinoma.
    Lal G, Padmanabha L, Smith BJ, Nicholson RM, Howe JR, O'Dorisio MS, Domann FE.
    Cancer; 2006 Dec 15; 107(12):2752-9. PubMed ID: 17103461
    [Abstract] [Full Text] [Related]

  • 11. Frameshift mutations of RIZ, but no point mutations in RIZ1 exons in malignant melanomas with deletions in 1p36.
    Poetsch M, Dittberner T, Woenckhaus C.
    Oncogene; 2002 May 02; 21(19):3038-42. PubMed ID: 12082534
    [Abstract] [Full Text] [Related]

  • 12. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M.
    Clin Cancer Res; 2005 Feb 01; 11(3):1119-28. PubMed ID: 15709179
    [Abstract] [Full Text] [Related]

  • 13. The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.
    Geli J, Kiss N, Lanner F, Foukakis T, Natalishvili N, Larsson O, Kogner P, Höög A, Clark GJ, Ekström TJ, Bäckdahl M, Farnebo F, Larsson C.
    Endocr Relat Cancer; 2007 Mar 01; 14(1):125-34. PubMed ID: 17395981
    [Abstract] [Full Text] [Related]

  • 14. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes.
    Moley JF, Brother MB, Fong CT, White PS, Baylin SB, Nelkin B, Wells SA, Brodeur GM.
    Cancer Res; 1992 Feb 15; 52(4):770-4. PubMed ID: 1346584
    [Abstract] [Full Text] [Related]

  • 15. A novel candidate region linked to development of both pheochromocytoma and head/neck paraganglioma.
    Cascón A, Ruiz-Llorente S, Rodríguez-Perales S, Honrado E, Martínez-Ramírez A, Letón R, Montero-Conde C, Benítez J, Dopazo J, Cigudosa JC, Robledo M.
    Genes Chromosomes Cancer; 2005 Mar 15; 42(3):260-8. PubMed ID: 15609347
    [Abstract] [Full Text] [Related]

  • 16. Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region.
    Fang W, Piao Z, Simon D, Sheu JC, Huang S.
    Genes Chromosomes Cancer; 2000 Jul 15; 28(3):269-75. PubMed ID: 10862032
    [Abstract] [Full Text] [Related]

  • 17. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
    Astuti D, Agathanggelou A, Honorio S, Dallol A, Martinsson T, Kogner P, Cummins C, Neumann HP, Voutilainen R, Dahia P, Eng C, Maher ER, Latif F.
    Oncogene; 2001 Nov 08; 20(51):7573-7. PubMed ID: 11709729
    [Abstract] [Full Text] [Related]

  • 18. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis.
    He L, Yu JX, Liu L, Buyse IM, Wang MS, Yang QC, Nakagawara A, Brodeur GM, Shi YE, Huang S.
    Cancer Res; 1998 Oct 01; 58(19):4238-44. PubMed ID: 9766644
    [Abstract] [Full Text] [Related]

  • 19. Modulation of RIZ gene expression is associated to estradiol control of MCF-7 breast cancer cell proliferation.
    Gazzerro P, Abbondanza C, D'Arcangelo A, Rossi M, Medici N, Moncharmont B, Puca GA.
    Exp Cell Res; 2006 Feb 01; 312(3):340-9. PubMed ID: 16356493
    [Abstract] [Full Text] [Related]

  • 20. Intra-tumoral molecular heterogeneity in benign and malignant pheochromocytomas and extra-adrenal sympathetic paragangliomas.
    Korpershoek E, Stobbe CK, van Nederveen FH, de Krijger RR, Dinjens WN.
    Endocr Relat Cancer; 2010 Sep 01; 17(3):653-62. PubMed ID: 20488782
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.